Diagnos Inc. Set to Hold Annual General Meeting on September 30, 2026

BROSSARD, Quebec, Sept. 14, 2026 /CourierPR/ -- Diagnos Inc., a Canadian company focused on early detection of eye-related health issues using artificial intelligence, is set to hold its annual general meeting of shareholders on September 30, 2026. The meeting, to be held at the Alt Quartier DIX30 Hotel in Brossard, Quebec, will commence at 10:00 a.m.

The primary agenda items for the meeting include the election of directors, the reappointment of Raymond Chabot Grant Thornton, LLP, as the independent auditor for the upcoming year, and the authorization of the board to set the auditor's remuneration. Shareholders are also encouraged to attend and vote in person or via proxy. Instructions for voting can be found in the 2026 Management Information Circular, which was mailed on September 3, 2026, and is available on SEDARplus.com.

All holders of common shares as of August 26, 2026, are eligible to participate. The Corporation advises shareholders to vote early by following the instructions provided in the meeting materials. If shareholders have not received their copies, they can contact their stockbroker or Computershare Trust Company of Canada at 1-800-564-6253.

Diagnos Inc. continues to leverage AI technologies to develop innovative products aimed at enhancing diagnostic accuracy, streamlining workflows, and improving patient outcomes. The company's dedication to early detection of critical eye-related health problems remains a cornerstone of its mission.